Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.
Press releases published on April 23, 2025
BPGbio Presents New Research on Tumor Metabolism, Immunotherapy, and Diagnostics at AACR Annual Meeting 2025
GlobeNewswire
·
April 23, 2025
BOSTON, April 23, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a leading biology-first, AI-powered clinical-stage biopharma company focused on mitochondrial biology and protein homeostasis, today announced the presentation of seven presentations at the American …
Seres Therapeutics to Announce First Quarter 2025 Financial Results and Business Updates on May 7, 2025
GlobeNewswire
·
April 23, 2025
CAMBRIDGE, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will host a conference call and live audio webcast on May 7, 2025 at 8:30 a.m. ET to …
First Atlantic Nickel Intersects 0.23% Nickel and 0.31% Chromium Over 366 Meters in Third Drill Hole at RPM Zone, Confirming at Least 500-Meter Mineralized Width
GlobeNewswire
·
April 23, 2025
VANCOUVER, British Columbia, April 23, 2025 (GLOBE NEWSWIRE) -- First Atlantic Nickel Corp. (TSXV: FAN) (OTCQB: FANCF) (FSE: P21) ("First Atlantic" or the "Company") is pleased to announce assay results from drill hole AN-24-04, the third drill hole at the …
Coave Therapeutics Expands into the US with Strategic Appointment of Romain Pettenaro as VP of Business Development
GlobeNewswire
·
April 23, 2025
Highly experienced in gene therapy dealmaking, Pettenaro will be driving Coave’s business development activities and establish its presence in the Boston biotech hub Paris, France, and Cambridge, MA, USA - April 23, 2025 – Coave Therapeutics (‘Coave’), a …
Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types
GlobeNewswire
·
April 23, 2025
LOUISVILLE, Colo. and HERCULES, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Biodesix, Inc (Nasdaq: BDSX), a leading diagnostics solutions company, and Bio-Rad Laboratories (NYSE: BIO), a global leader in life science research and diagnostics products, …
Port of Helsingborg Advances Digital Transformation with N4 Terminal Operating System, Reduces Rehandles by 50 Percent
GlobeNewswire
·
April 23, 2025
HELSINGBORG, Sweden, April 23, 2025 (GLOBE NEWSWIRE) -- Port of Helsingborg, Sweden's second largest container terminal, continues to advance its modernization initiatives using the N4 Terminal Operating System (TOS) from Kaleris, a leading provider of …
Precore Gold Granted Option to Acquire Arikepay Porphyry Gold-Copper Property in Peru
GlobeNewswire
·
April 23, 2025
VANCOUVER, British Columbia, April 23, 2025 (GLOBE NEWSWIRE) -- Precore Gold Corp. (CSE: PRCG) (the “Company” or “Precore Gold”) is pleased to announce that it has entered into a Definitive Option Agreement (the “Option Agreement”) with Alta Copper Corp. ( …
Tandem Workforce and NuPaths Partner to Address the IT Talent Shortage with Scalable, Retention-Focused Model
GlobeNewswire
·
April 23, 2025
ENOLA, Pa., April 23, 2025 (GLOBE NEWSWIRE) -- Tandem Workforce and NuPaths today unveiled a first-of-its-kind collaboration that promises to transform how companies build and maintain their IT departments. This innovative partnership combines NuPaths' …
Barebone Budgeting Launches on the App Store to Help Uncover Hidden Expenses
GlobeNewswire
·
April 23, 2025
Washington, DC, April 23, 2025 (GLOBE NEWSWIRE) -- As living expenses continue to rise and household budgets face increasing pressures, many individuals feel they’ve exhausted all possible ways to cut back. Barebone Budgeting has officially launched on the …
Pharming receives positive recommendation from NICE for Joenja®▼(leniolisib) as a treatment for APDS
GlobeNewswire
·
April 23, 2025
For media and investors only Joenja® is the first and only medicine specifically for APDS to be reimbursed within the NHS Recommended for adult and pediatric patients 12 years of age and older with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome …
Cytovation Raises US$6m to Advance Phase 2 Development of CY-101 in Adrenocortical Carcinoma to First Clinical Readouts
GlobeNewswire
·
April 23, 2025
New funds provided largely by existing investors, led by Sandwater Phase 2 trial to be delivered through novel agreement between Cytovation, Cancer Research UK and the Norwegian Cancer Society New preclinical data highlighting potential of CY-101 in ACC …